Keynote Financial Services’s Medtronic MDT Stock Holding History

Keynote Financial Services’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$751K	Sell	8,672 -63	-0.7%	-$6.04K	0.4%	72
2025 Q4	$839K	Sell	8,735 -288	-3%	-$28K	0.47%	63
2025 Q3	$859K	Buy	9,023 +1,354	+18%	+$124K	0.52%	58
2025 Q2	$669K	Sell	7,669 -425	-5%	-$36K	0.45%	67
2025 Q1	$727K	Sell	8,094 -10	-0.1%	-$895	0.52%	59
2024 Q4	$647K	Buy	8,104 +72	+0.9%	+$6.23K	0.5%	61
2024 Q3	$723K	Sell	8,032 -400	-5%	-$33.6K	0.55%	52
2024 Q2	$664K	Sell	8,432 -90	-1%	-$7.38K	0.56%	55
2024 Q1	$743K	Buy	+8,522	New	+$727K	0.62%	52

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Keynote Financial Services's MDT Position: Q1 2026 in Review

Keynote Financial Services reduced its Medtronic (MDT) stake by 0.72% in Q1 2026, selling an estimated $6.04K and leaving 8,672 shares worth $751K. The position accounts for 0.4% of the portfolio, ranked #72.

Keynote Financial Services first reported a position in MDT in Q1 2024 and has held it in 9 quarters since. The position peaked at $859K in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Keynote Financial Services held 8,672 shares of Medtronic worth $751K as of Q1 2026.
Keynote Financial Services sold 63 Medtronic shares in Q1 2026, an estimated $6.04K.
Medtronic made up 0.4% of Keynote Financial Services's portfolio in Q1 2026, its #72 holding.
Keynote Financial Services first reported a position in Medtronic in Q1 2024 and has held it in 9 quarters since.
Keynote Financial Services's Medtronic position peaked at $859K in Q3 2025.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Keynote Financial Services's 13F filing for Q1 2026, filed 13 May 2026.